Platelet deposition onto polymeric surfaces during shunting

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Medical Device Engineering

Background:

• Heparinization is crucial for blood-contacting medical devices to prevent thrombosis.
• Developing materials that are inherently blood-compatible could reduce or eliminate the need for anticoagulants like heparin.
• Evaluating polymer blood compatibility is essential for advancing short-term medical applications.

Purpose of the Study:

• To assess the blood compatibility of various polymeric materials for short-term blood-contacting tubes.
• To compare the performance of unmodified polymers (silicone, PVC, PU) with surface-modified versions (PVA-coated PVC, PDMAA-grafted PU).
• To establish a correlation between ex vivo shunt results and in vitro protein adsorption and platelet adhesion.

Main Methods:

• Utilized a rabbit ex vivo shunt model to evaluate blood compatibility.
• Employed silicone, plasticized poly(vinyl chloride) (PVC), and segmented poly(ether urethane) (PU) shunt tubes.
• Investigated surface-modified tubes: poly(vinyl alcohol) (PVA)-coated PVC and poly(dimethylacrylamide) (PDMAA)-grafted PU.

Main Results:

• Ex vivo shunt results correlated with in vitro protein adsorption and platelet adhesion.
• Platelet deposition order was: PDMAA-grafted PU < PVA-coated PVC < PU < silicone, PVC.
• PDMAA-grafted PU exhibited minimal platelet adhesion with no aggregate detachment observed, unlike PVA-coated PVC.

Conclusions:

• Poly(dimethylacrylamide)-grafted poly(ether urethane) demonstrates excellent blood compatibility, showing minimal platelet adhesion and no aggregate detachment.
• Surface modification with PDMAA significantly enhances the hemocompatibility of poly(ether urethane) for blood-contacting applications.
• The study suggests PDMAA-grafted PU is a promising material for blood-contacting tubes, potentially reducing or eliminating the need for heparinization.